Prestige Consumer Healthcare Inc. (PBH) — RQD Stock Rating Cockpit

Per the Roarable RQD rating, PBH scores 60 out of 100, a C- grade labeled "Roarable Hold — Cautious Neutral." The five pillars are: Fundamental Cash Engine at 14/20 (ROIC 13.8%; FCF yield 10.67%); Whale 13F Flow at 7/20 (institutional accumulation and options positioning); Insider Conviction at 17/20 (SEC Form 4 and Congressional PTR cluster flow); Macro Regime Fit at 11/20 (Beta 1.0; sector sensitivity); and Forensic Balance Sheet at 11/20 (Altman Z 2.21; Piotroski F 6/9; Debt/Equity 0.5).

For a prospective investor, the strongest pillar is insider conviction, and the cash-generation pillar is solid, with a 10.67% FCF yield supporting the valuation narrative. The weakest pillar is institutional flow at 7/20, which indicates limited evidence of institutional accumulation in the source data. The Macro Regime Fit and Forensic Balance Sheet pillars both sit at 11/20, signaling a middling position on market sensitivity and balance-sheet health. The overall verdict of "Cautious Neutral" suggests the rating does not currently support an aggressive stance in either direction. The valuation metrics (P/E TTM 12.1, EV/EBITDA 7) appear modest in the source data, but a prospective investor should weigh these against the weak institutional-flow reading and the absence of analyst coverage.

Per the market data, gross margin is 54.7%, operating margin 28.4%, and net margin 17.5%, with ROIC of 13.8%. Per the Roarable RQD rating, the Altman Z-Score is 2.21 and the Piotroski F-Score is 6/9, with Debt/Equity at 0.5. Revenue declined from $1137.8M in FY 2024 to $1088.7M in FY 2025, and net income declined from $214.6M to $190.3M over the same period. FCF remained relatively stable across the three reported periods.

Per the recent news and catalysts feed, six items relate to PBH, all rated YELLOW and tagged MARKET WIRE. They include a Yahoo! Finance Canada market report, a Yahoo Finance piece on whether to retain the stock, a TradingView estimates page, a Benzinga transcript of the Q1 2027 earnings conference call, a Simply Wall St article stating the stock could be undervalued after raising revenue guidance, and a Yahoo Finance notice of an upcoming fiscal 2027 second-quarter earnings release. The Simply Wall St headline indicates a revenue guidance raise; the source does not provide the guidance figures. Per the Butterfly Supply-Chain Graph, the supply chain is listed as NONE, with no butterfly links and no proprietary signals.

• What specific revenue guidance was raised, and by how much, according to the Simply Wall St report?
• What products and customer segments generate PBH's revenue, given the source describes only sector classification?
• Why did revenue and net income decline from FY 2024 to FY 2025, and what drove the change?
• What is the company's debt position in FY 2025, given the source lists debt as N/A for that period?
• Who are the institutional holders and insiders behind the 7/20 flow and 17/20 insider scores, given the holders section is empty?